Weight loss interventions and progression of diabetic kidney disease (Q38539937)

3 September 2017

1 reference

title

Weight loss interventions and progression of diabetic kidney disease (English)

1 reference

3 September 2017

1

0 references

Carel le Roux

object named as

Carel W le Roux

series ordinal

3

0 references

author name string

Aoife L Canney

series ordinal

2

1 reference

3 September 2017

1 August 2015

1 reference

3 September 2017

Current diabetes report

1 reference

3 September 2017

15

1 reference

3 September 2017

8

1 reference

3 September 2017

55

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-015-0625-2

3 September 2017

0 references

cites work

Neurobiology of food intake in health and disease

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Body mass index and risk for end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Kidney disease and increased mortality risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Obesity, metabolic syndrome and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Macrophages and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Molecular mechanisms of diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Mechanisms of diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Kidney function in early diabetes: the tubular hypothesis of glomerular filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Microalbuminuria and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Updating the natural history of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Animal versus plant protein meals in individuals with type 2 diabetes and microalbuminuria: effects on renal, glycemic, and lipid parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Effects of weight loss on renal function in obese CKD patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Improvement in albuminuria in patients with type 2 diabetes after laparoscopic adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

The effect of biliopancreatic diversion surgery on renal function--a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Benefits of a 12-week lifestyle modification program including diet and combined aerobic and resistance exercise on albuminuria in diabetic and non-diabetic Japanese populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Short-term changes after a weight reduction intervention in advanced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0625-2

Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes

21 January 2018

1 reference

12 December 2020

Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy

1 reference

12 December 2020

Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus

1 reference

12 December 2020

Nephrin Is Critical for the Action of Insulin on Human Glomerular Podocytes

1 reference

12 December 2020

Improved renal function 12 months after bariatric surgery

1 reference

12 December 2020

Free Fatty acids and their metabolism affect function and survival of podocytes

1 reference

12 December 2020

Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia

1 reference

12 December 2020

The effect of weight loss after bariatric surgery on albuminuria.

1 reference

12 December 2020

Role of T cells in type 2 diabetic nephropathy

1 reference

12 December 2020

Incretins or anti-incretins? A new model for the "entero-pancreatic axis".

1 reference

12 December 2020

10.1007/S11892-015-0625-2

Identifiers

DOI

1 reference

PubMed ID

26122095

Dimensions Publication ID

3 September 2017

1012672434

0 references

Fatcat ID

release_zeom3xqxwrcodosx63qf26zidq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zeom3xqxwrcodosx63qf26zidq

24 November 2022

mapped directly with Wikidata item

PubMed ID

26122095

1 reference

PubMed ID

26122095